AbbVie Inc (ABBV) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $263.96 (-0.02%), Market cap $378.98B, P/E ratio 105.15, 52-week low–high $182.31 ~ $244.38.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Ju
Financial statements, price targets, institutional (13F) holdings and related news for AbbVie Inc are updated in real time on BlackAll Trade.
5 recent posts · 4 bullish · 0 bearish · 1 neutral.
AbbVie Inc trades at $263.96 (-0.02%). Real-time quotes and charts are available on BlackAll Trade.
AbbVie Inc has a market cap of about $378.98B. Its P/E ratio is 105.15.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyr